Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.680
-0.020 (-1.18%)
Apr 29, 2026, 12:55 PM EDT - Market open
Pyxis Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -79.62 | -77.33 | -73.79 | -120.72 | -75.98 | |
| Depreciation & Amortization | 4.51 | 2.98 | 1.93 | 0.71 | 0.65 | |
| Asset Writedown & Restructuring Costs | - | 20.96 | - | 9.28 | 20 | |
| Loss (Gain) From Sale of Investments | -2.96 | -6.11 | -4.79 | - | - | |
| Loss (Gain) on Equity Investments | - | - | - | - | 0.05 | |
| Stock-Based Compensation | 11.8 | 12.95 | 16.95 | 15.76 | 6.44 | |
| Other Operating Activities | 0.82 | 0.7 | 0.66 | 1.13 | 6.84 | |
| Change in Accounts Payable | 6.03 | 1.2 | -3.51 | -8.33 | 4.64 | |
| Change in Unearned Revenue | - | -7.66 | 1 | - | - | |
| Change in Other Net Operating Assets | -4.08 | -3.2 | -9.16 | 12.83 | 2.03 | |
| Operating Cash Flow | -63.5 | -57.67 | -70.71 | -89.34 | -35.33 | |
| Capital Expenditures | -0.01 | -0.24 | -6.73 | -6.4 | -0.54 | |
| Cash Acquisitions | - | - | 6.66 | - | - | |
| Investment in Securities | 58.87 | 8.39 | -104.78 | - | -0.05 | |
| Investing Cash Flow | 58.86 | 8.16 | -104.85 | -6.4 | -0.59 | |
| Issuance of Common Stock | 0.74 | 51.87 | 6.37 | 0.18 | 152.46 | |
| Repurchase of Common Stock | -0.15 | -0.24 | -0.45 | - | - | |
| Other Financing Activities | - | 7.7 | - | - | - | |
| Financing Cash Flow | 0.59 | 59.33 | 5.93 | 0.18 | 304.04 | |
| Net Cash Flow | -4.05 | 9.81 | -169.63 | -95.55 | 268.13 | |
| Free Cash Flow | -63.51 | -57.91 | -77.44 | -95.73 | -35.87 | |
| Free Cash Flow Margin | -458.30% | -358.66% | - | - | - | |
| Free Cash Flow Per Share | -1.02 | -0.99 | -1.94 | -2.90 | -4.22 | |
| Cash Interest Paid | 0.09 | 0.01 | 0 | - | - | |
| Cash Income Tax Paid | 1.38 | 0.16 | 0.05 | 0.02 | - | |
| Levered Free Cash Flow | -31.38 | -33.79 | -43.21 | -57.39 | -25.47 | |
| Unlevered Free Cash Flow | -31.38 | -33.79 | -43.21 | -57.39 | -25.47 | |
| Change in Working Capital | 1.94 | -11.82 | -11.66 | 4.5 | 6.68 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.